OnKommon
OnKommon is the molecular-intelligence and technology ecosystem connected with KPCIRC. It helps organise genomic findings, clinical context, treatment intelligence, emerging evidence and research workflows. KPCIRC provides the clinical service pathways and governance; OnKommon has its own product and technology identity.
Research Use Only where labelled
Longitudinal cancer intelligence
TWIN is conceived as an evolving digital model of the cancer journey, bringing molecular, clinical, imaging, treatment and evidence information into a longitudinal view. The published product specification describes 21 analytical layers and a six-month pathway. Detailed features, test pathways and technical documentation are on OnKommon.com.
Details on OnKommon.com (opens in a new tab)Investigational · Research Use Only
Investigational biological discovery
AVATAR combines computational interpretation with an investigational fruit-fly modelling and candidate-drug screening process. A response observed in a model is not proof of efficacy in a person, and AVATAR is not a validated clinical prediction of an individual’s treatment response.
Details on OnKommon.com (opens in a new tab)KPCIRC clinical service pathway
KPCIRC’s report-interpretation service
POAS is KPCIRC’s Precision Oncology Analysis Service for existing NGS and relevant molecular reports. It structures variant context, tumour biology, immunotherapy-associated evidence, therapeutic evidence, trial context and access information for clinician-led assessment. POAS is not a synonym for any OnKommon product.
Explore POASClinical pathways, service delivery, clinician collaboration, MTB review and defined clinical governance.
Molecular-intelligence tools, digital-twin concepts, analytical workflows and investigational discovery products.
Retains patient-specific clinical responsibility and makes treatment decisions within the applicable care arrangement.
Scientific boundaries and transparency
Research-use-only and investigational software and findings are clearly labelled. No OnKommon product independently diagnoses cancer, prescribes treatment or guarantees response. Detailed product information lives on OnKommon.com so it is not duplicated here.
